Report Summary
India, with a healthcare market standing nearly at US$ 38 Billion in 2007, represents one of the most emerging healthcare products and services market in the world. Out report "Indian Healthcare - New Avenues for Growth"expects the potential of this market to increase several fold in next five years.
India represents the world’s second largest populated country. With a rapidly expanding economy and increasing urbanization, the prevalence of a number of chronic diseases, such as cardiovascular, diabetes, arthritis and cancer, has increased rapidly in India. So the country is becoming a source of opportunities for players operating in these segments.
"Indian Healthcare - New Avenues for Growth" report contains unique market-based research and provides a detailed and objective analysis on the Indian healthcare market. It offers a thorough statistical and analytical overview of the Indian healthcare market coupled with past, present and future forecast till 2012 on the entire structure, composition and working of the Indian healthcare sector. It studies a number of lucrative sectors such as hospital services, pharmaceuticals, medical devices, outsourcing services, infrastructure, and path labs together with a number of other sectors.
The report concludes that although India’s healthcare represents one of the biggest opportunity areas, it faces a number of challenges, like affordability and accessibility of healthcare, lack of government support and lack of awareness regarding quality healthcare services. However, the country is working towards overcoming these challenges and matching the standards of developed countries.
Key Findings of the Report
Total healthcare spending in India is expected to grow at a CAGR of 17% between 2007 and 2012.
In India, 80% of healthcare payments are still paid out-of-pocket.
Around 76 Million Indians are expected to be above 65 years of age by 2012, thereby increasing the prevalence of several chronic diseases.
India, with one of largest population with diabetes and cardiovascular diseases, has created a huge opportunity for healthcare products and services for these indications.
The large-scale prevalence of both infectious and lifestyle-related diseases has created a big opportunity for the IVD market in India.
Strong human resources and cost advantage has enabled India to emerge as a strong outsourcing destination.
Key Issues & Facts Analyzed in the Report
Evaluation of past, current and future market trends.
Segment-wise analysis of the market.
Discussion about the major drivers of the healthcare market.
Analysis of the opportunities created by the market.
Overview on the major challenges for the market.
Study of the competitive landscape of the market.
Research Methodology Used in the Report
Information Sources
Information has been sourced from books, newspapers, trade journals, white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to over 3000 paid databases.
Analysis Methods
RNCOS industry forecast and analysis is based on various macro- and microeconomic factors, sector and industry specific databases, and our in-house statistical and analytical model. This model takes into account the past and current trends in an economy, and more specifically in an industry, to bring out an objective market analysis.
Our industry experts study the relationship between various industry and economic variables to ensure the required accuracy and desired check on the quality of data and information given in the report.
Report Outline
1. Analyst View
2. The Indian Healthcare Market
3. What Makes India Such a Lucrative Market
3.1 Population
3.2 Epidemiological Transitions
3.3 Rising Income
3.4 Increasing Health Insurance Penetration
3.5 Improving Medical Infrastructure
4. Healthcare Indicators & Demographics To 2012
4.1 Healthcare Spending
4.2 Source of Funding
4.3 Demographics
4.4 Healthcare Institutions
4.5 Healthcare Professionals
4.6 Leading Causes of Death
5. Emerging Sectors To 2012
5.1 Hospital Services
5.2 Pharmaceuticals
5.3 Medical Tourism
5.4 Medical Infrastructure
5.5 Medical Devices
5.6 Pharma Outsourcing
5.7 Health Outsourcing
5.8 Path Labs
5.9 Medical Textiles
5.10 Health Insurance
5.11 Healthcare Training & Education Services
6. Analysis by Disease Type
6.1 Cardiovascular
6.2 Diabetes
6.3 Oncology
6.4 HIV
6.5 IVD
7. Industry Roadblocks
7.1 Affordability & Accessibility
7.2 Government Support
7.3 Lack of Standardization
7.4 Currency Fluctuations
Figures
Figure 2-1: India - Healthcare Market (in Billion US$), 2006 & 2007
Figure 2-2: India - Healthcare Market by Sector (%), 2006 & 2007
Figure 2-3: India - Forecast for Healthcare Market (in Billion US$), 2008-2012
Figure 2-4: India - CAGR of Healthcare Market by Sector (%), 2007 to 2012
Figure 2-5: India - Forecast for Healthcare Market by Sector (%), 2008-2012
Figure 3-1: India - Population (in Billion), 2001-2007
Figure 3-2: India - Forecast for Population (in Billion), 2008-2012
Figure 3-3: India - Prevalence of various Lifestyle-related Diseases (in Million), 2005 & 2015
Figure 3-4: India - Income Distribution among Households (%), 1989-90, 2001-02 & 2006-07
Figure 4-1: India - Healthcare Spending (in Billion US$), 2001-2007
Figure 4-2: India - Forecast for Healthcare Spending (in Billion US$), 2008-2012
Figure 4-3: India - Healthcare Payments by Source (%)
Figure 4-4: India - Life Expectancy (in Years), 2001-2007
Figure 4-5: India - Forecast for Life Expectancy (in Years), 2008-2012
Figure 4-6: India - Population by Gender (%), 2003-2006
Figure 4-7: India - Population Breakup by Age Group (%), 2001-2007
Figure 4-8: India - Forecast for Population Breakup by Age Group (%), 2008-2012
Figure 4-9: India - Number of Hospital Beds (per ‘000 Population), 2006 & 2012
Figure 4-10: India - Number of Doctors (in ‘000), 2005-2007
Figure 4-11: India - Forecast for Number of Doctors (in ‘000), 2008-2011
Figure 4-12: India - Number of Nurses (in ‘000), 2004-2007
Figure 4-13: India - Forecast for Number of Nurses (in ‘000), 2008-2011
Figure 4-14: India - Number of Deaths due to Leading Causes (in ‘000), 2005
Figure 4-15: India - Leading Causes of Death (%), 2005
Figure 4-16: India - Forecast for Leading Causes of Death (%), 2030
Figure 5-1: India - Forecast for Bed Revenues (in Billion US$), 2006-2012
Figure 5-2: India - Hospitalization Cases by Type of Diseases (%), 2006
Figure 5-3: India - Bed Occupancy Rate (%)
Figure 5-4: India - Domestic Pharmaceutical Market (in Billion INR), 2001-02 to 2007-08
Figure 5-5: India - Domestic Pharmaceutical Market by Drug Category (%), 2004
Figure 5-6: India - Forecast for Domestic Pharmaceutical Market by Drug Category (%), 2010
Figure 5-7: India - Domestic Pharmaceutical Market by Therapeutic Category (%), 2007
Figure 5-8: India - Forecast for CAGR of Major Therapeutic Categories (%), 2007 to 2011
Figure 5-9: India - Forecast for Domestic Pharmaceutical Market (in Billion INR), 2008-09 to 2012-13
Figure 5-10: India - Forecast for Medical Tourist Arrivals (in ‘000), 2006-2012
Figure 5-11: India - Forecast for Medical Tourism Market (in Million US$), 2006-2012
Figure 5-12: India - Forecast for Medical Infrastructure Market (in Billion US$), 2006-2012
Figure 5-13: India - Number of Beds (in ‘000), 2006 & 2012
Figure 5-14: India - Healthcare Floor Space (in Million Sq. ft), 2006 & 2012
Figure 5-15: India - Healthcare Land Area (in Acre), 2006 & 2012
Figure 5-16: India - Medical Infrastructure Market by Segment (%), 2006
Figure 5-17: India - Forecast for Medical Devices Market (in Billion US$), 2006-2012
Figure 5-18: India - Medical Devices Market by Type (%)
Figure 5-19: India - Pharma Outsourcing Market (in Million US$), 2004, 2006 & 2007
Figure 5-20: India - Pharma Outsourcing Market by Segment (%), 2006
Figure 5-21: India - Forecast for Pharma Outsourcing Market (in Million US$), 2008-2012
Figure 5-22: India - Forecast for Pharma Outsourcing Market by Segment (%), 2011
Figure 5-23: India - Forecast for Health Outsourcing Market (in Billion US$), 2006-2012
Figure 5-24: India - Forecast for Independent Path Lab Market (in Billion US$), 2006-2012
Figure 5-25: India - Classification of Medical Textiles
Figure 5-26: India - Forecast for Medical Textiles Market (in Million US$), 2006-2012
Figure 5-27: India - Medical Textiles Market by Segment (%), 2007-08
Figure 5-28: India - Forecast for Medical Textiles Market by Segment (%), 2009-10
Figure 5-29: India - Forecast for Health Insurance Market (in Billion US$), 2006-2012
Figure 5-30: India - Share of Public/Private Sector Companies in Health Insurance Market (%), 2005-06
Figure 5-31: India - Share of Major Companies in Private Health Insurance Market (%), 2005-06
Figure 5-32: India - Forecast for Healthcare Training & Education Services Market (in Billion US$), 2006-2012
Figure 6-1: India - Number of Coronary Heart Patients (in Million), 2005 & 2015
Figure 6-2: India - Cardiac Drugs Market (in Billion INR), 2006, 2007 & 2011
Figure 6-3: India - Number of Diabetic Patients (in Million), 2007 & 2025
Figure 6-4: India - Diabetes Market (in Billion INR), 2006, 2007 & 2011
Figure 6-5: India - New & Total Number of Cancer Patients (in Million)
Figure 6-6: India - Cancer Drugs Market (in Million US$), 2007 & 2012
Figure 6-7: India - Prevalence of HIV (%), 2002 & 2007
Figure 6-8: India - Antiretroviral Market (in Million INR), 2006, 2007 & 2012
Figure 6-9: India - IVD Market* (in Million US$), 2006 & 2007
Figure 6-10: India - IVD Market by Segment (%), 2006
Figure 6-11: India - Forecast for IVD Market (in Million US$), 2008-2012
Figure 7-1: India - Per Capita Healthcare Spending w.r.t Other Major Countries (in US$), 2007
Figure 7-2: Global - Share of State & Personal Financing in Top Pharmaceutical Markets (%), 2006
Tables
Table 5-1: India - Cost of Various Surgical Procedures w.r.t. Other Countries (in US$)
